Philips wins FDA clearance for next-gen digital pathology system
July 12, 2024
Philips (NYSE: PHG)+
announced today that it received FDA clearance for its latest pathology solution, the IntelliSite Pathology Solution 5.1.
Philips (NYSE: PHG)+
announced today that it received FDA clearance for its latest pathology solution, the IntelliSite Pathology Solution 5.1.
Oticon Medical announced today that the FDA granted clearance for its Sentio transcutaneous bone conduction hearing system.